Clinical Trials & Research at Baptist
Research is an important aspect of the health care industry. Baptist Memorial Health Care conducts in-depth research in many areas to help determine the safety and effectiveness of new treatments and medications.
Baptist Clinical Research Institute
The Baptist Clinical Research Institute is a hospital-based research center that conducts patient studies called clinical trials (research protocols) to help develop leading-edge medical care for patients.
Areas of Research:
- Cardiac/vascular surgery
- Pulmonary medicine
- Emergency medicine
For More Information, Contact:
Baptist Cancer Center Clinical Trials
The Baptist Cancer Center conducts clinical trials to ensure the advancement of our research efforts to help expand and improve our approach to cancer treatment. The cancer clinical trials cover a variety of cancers including breast oncology, head and neck oncology, experimental therapeutics program and malignant hematology program.
Institutional Review Board (IRB)
The Baptist Memorial Health Care Corporation-Institutional Review Board (BMHCC-IRB) is a committee of physicians, statisticians, researchers, community advocates and others that ensures a clinical trial is ethical and the rights of study participants are protected.
By federal regulation, all clinical trials in the U.S. must be approved by an IRB before they begin. At Baptist, the IRB initially approves and periodically reviews the research in order to protect the rights of human participants.
All research studies performed using any Baptist facility must be reviewed by the BMHCC-IRB. All research proposals must be submitted to the IRB two (2) weeks prior to the next scheduled meeting (see schedule below). Four (4) weeks prior to study expiration date is suggested for renewals. Please download the appropriate documents for your submission.
Human Research Protection Program (HRPP)
Applications and Forms
- Initial Application to Conduct Human Subject Research
- Application to Conduct Research Using Existing Medical Records
- Application to Conduct Research Using Existing Medical Records (Residents & Students)
- Application to Amend an Approved Protocol or Consent Form
- Application for Continuing Review of Research
- Application Checklist for Students and Residents
- Final Report–Study Closure
- HUD Initial Application
- HUD Initial Application Neuroscience
- HUD Continuing Review
- Directions and Information for Emergency Use of an FDA-regulated Product
- Emergency Use Informed Consent Form
- Informed Consent Form Template
- Application for Research Exempt from IRB Review
- Protocol Deviation/Violation Form
- Request to Use External IRB
- Serious Adverse Event Form
- 2014 IRB Resource Guide
- Protections of Human Subjects
- FDA Code of Federal Regulations Part 21 Title 50
- Health and Human Services Policy and Guidance
- Federal Policy for the Protection of Human Subjects The Belmont Report – ('Common Rule')
Submission Deadline & Meeting Dates
|Submission Deadline||Meeting Date|
|June 7, 2017||June 22, 2017|
|June 28, 2017||July 13, 2017|
|July 12, 2017||July 27, 2017|
|July 26, 2017||August 10, 2017|
|August 9, 2017||August 24, 2017|
|August 23, 2017||September 14, 2017|
|September 13, 2017||September 28, 2017|
|September 27, 2017||October 12, 2017|
|October 11, 2017||October 26, 2017|
|November 1, 2017||November 16, 2017|
|December 6, 2017||December 21, 2017|
Deadline for all submissions is two (2) weeks prior to the next scheduled IRB meeting. All submissions are due by 4:30 p.m. (CST) on the deadline date. Four (4) weeks prior to study expiration date is suggested for renewals.
Baptist Memorial Health Care Corporation Institutional
For information regarding possible trials, please contact the BMHCC Institutional Review Board: